130 related articles for article (PubMed ID: 38447455)
1. Generation of an induced pluripotent stem cell line (KNIHi001-A) by reprogramming peripheral blood mononuclear cells isolated from a patient with Parkinson's disease.
Baek D; Lee KG; Sohn HY; Park JH; Lee HK; Bayarsaikhan G; Yoo SW; Lee B; Kim JS; Koh YH; Kwon M
Stem Cell Res; 2024 Apr; 76():103358. PubMed ID: 38447455
[TBL] [Abstract][Full Text] [Related]
2. Derivation of human induced pluripotent stem cell (iPSC) line from a 79year old sporadic male Parkinson's disease patient.
Zhang S; Liu L; Hu Y; Lv Z; Li Q; Gong W; Sha H; Wu H
Stem Cell Res; 2017 Mar; 19():43-45. PubMed ID: 28413004
[TBL] [Abstract][Full Text] [Related]
3. Generation of a human induced pluripotent stem cell (iPSC) line from a 64year old male patient with multiple schwannoma.
Zhang S; Lv Z; Hu Y; Liu L; Gong W; Li Q; Wu H
Stem Cell Res; 2017 Mar; 19():49-51. PubMed ID: 28413006
[TBL] [Abstract][Full Text] [Related]
4. Development of human induced pluripotent stem cell (iPSC) line from a 60year old female patient with multiple schwannoma.
Zhang S; Lv Z; Liu Y; Li Q; Gong W; Liu L; Wu H
Stem Cell Res; 2017 Mar; 19():31-33. PubMed ID: 28413001
[TBL] [Abstract][Full Text] [Related]
5. Generation of a human induced pluripotent stem cell line (CSC-42) from a patient with sporadic form of Parkinson's disease.
Savchenko E; Marote A; Russ K; Collin A; Goldwurm S; Roybon L; Pomeshchik Y
Stem Cell Res; 2018 Mar; 27():78-81. PubMed ID: 29334629
[TBL] [Abstract][Full Text] [Related]
6. Generation and characterisation of a human induced pluripotent stem cell line, NIMHi007-A, from peripheral blood mononuclear cells derived from an adult healthy female.
Nimonkar MM; Arunachal G; Dash SS; Kandy SK; Raghavendra K; Chetan GK; Mehta B; Markandeya YS
Stem Cell Res; 2023 Aug; 70():103130. PubMed ID: 37269666
[TBL] [Abstract][Full Text] [Related]
7. Establishment of a human iPSC line (MUSIi007-A) from peripheral blood of normal individual using Sendai viral vectors.
Potirat P; Wattanapanitch M; Kheolamai P; Issaragrisil S
Stem Cell Res; 2018 Oct; 32():43-46. PubMed ID: 30172906
[TBL] [Abstract][Full Text] [Related]
8. Generation of an induced pluripotent stem cell line (ZZUi034-A) from a 65 year old Chinese female donor with sendai virus reprogramming protocol.
Zhang Y; Zhu J; Dai Y; Wang L; Liu R; Guo X
Stem Cell Res; 2022 Jul; 62():102788. PubMed ID: 35462158
[TBL] [Abstract][Full Text] [Related]
9. Establishment of an induced pluripotent stem cell line (ZZUSAHi002-A) derived from peripheral blood mononuclear cells of a healthy individual.
Liu S; Niu S; Li Y; Xiong H; Li Y; Jian L; Zhang L
Stem Cell Res; 2020 Oct; 48():101966. PubMed ID: 32911326
[TBL] [Abstract][Full Text] [Related]
10. Characterization of human induced pluripotent stem cell (iPSC) line from a 72year old male patient with later onset Alzheimer's disease.
Zhang S; Lv Z; Zhang S; Liu L; Li Q; Gong W; Sha H; Wu H
Stem Cell Res; 2017 Mar; 19():34-36. PubMed ID: 28413002
[TBL] [Abstract][Full Text] [Related]
11. Derivation of human induced pluripotent stem cell (iPSC) line with LRRK2 gene R1398H variant in Parkinson's disease.
Ma D; Tio M; Ng SH; Li Zeng ; Lim CY; Zhao Y; Tan EK
Stem Cell Res; 2017 Jan; 18():48-50. PubMed ID: 28395803
[TBL] [Abstract][Full Text] [Related]
12. Characterization of human induced pluripotent stem cells line (PNUSCRi004-A) from a Parkinson's disease patient carrying L483P, A495P and V499V mutations.
Moon HJ; Lee N; Moon JY; Lee JH; Kim JH
Stem Cell Res; 2023 Apr; 68():103051. PubMed ID: 36805467
[TBL] [Abstract][Full Text] [Related]
13. Reprogramming of a human induced pluripotent stem cell (iPSC) line from a Parkinson's disease patient with a R1628P variant in the LRRK2 gene.
Ma D; Zhou W; Ng EY; Zeng L; Zhao Y; Tan EK
Stem Cell Res; 2017 Jan; 18():45-47. PubMed ID: 28395802
[TBL] [Abstract][Full Text] [Related]
14. Efficient Generation of Non-Integration and Feeder-Free Induced Pluripotent Stem Cells from Human Peripheral Blood Cells by Sendai Virus.
Ye H; Wang Q
Cell Physiol Biochem; 2018; 50(4):1318-1331. PubMed ID: 30355953
[TBL] [Abstract][Full Text] [Related]
15. Generation of induced pluripotent stem cell line, NIMHi009-A, from PBMCs of an adult healthy male.
Arunachal G; Milind Nimonkar M; Raghavendra K; Chetan GK; Mehta B; Markandeya YS
Stem Cell Res; 2024 Apr; 76():103349. PubMed ID: 38368738
[TBL] [Abstract][Full Text] [Related]
16. Generation of a human induced pluripotent stem cell (iPSC) line carrying the Parkinson's disease linked LRRK2 variant S1647T.
Ma D; Ng SH; Zeng L; Zhao Y; Tan EK
Stem Cell Res; 2017 Jan; 18():54-56. PubMed ID: 28395805
[TBL] [Abstract][Full Text] [Related]
17. Generation and characterization of human induced pluripotent stem cell line METUi001-A from a 25-year-old male patient with relapsing-remitting multiple sclerosis.
Begentas OC; Koc D; Yurtogullari S; Temel M; Akcali KC; Demirkaya S; Kiris E
Stem Cell Res; 2021 May; 53():102370. PubMed ID: 34087999
[TBL] [Abstract][Full Text] [Related]
18. Efficient Reprogramming of Canine Peripheral Blood Mononuclear Cells into Induced Pluripotent Stem Cells.
Kimura K; Tsukamoto M; Tanaka M; Kuwamura M; Ohtaka M; Nishimura K; Nakanishi M; Sugiura K; Hatoya S
Stem Cells Dev; 2021 Jan; 30(2):79-90. PubMed ID: 33256572
[TBL] [Abstract][Full Text] [Related]
19. Generation of Patient-Specific induced Pluripotent Stem Cell from Peripheral Blood Mononuclear Cells by Sendai Reprogramming Vectors.
Quintana-Bustamante O; Segovia JC
Methods Mol Biol; 2016; 1353():1-11. PubMed ID: 25523810
[TBL] [Abstract][Full Text] [Related]
20. Robust and highly efficient hiPSC generation from patient non-mobilized peripheral blood-derived CD34
Okumura T; Horie Y; Lai CY; Lin HT; Shoda H; Natsumoto B; Fujio K; Kumaki E; Okano T; Ono S; Tanita K; Morio T; Kanegane H; Hasegawa H; Mizoguchi F; Kawahata K; Kohsaka H; Moritake H; Nunoi H; Waki H; Tamaru SI; Sasako T; Yamauchi T; Kadowaki T; Tanaka H; Kitanaka S; Nishimura K; Ohtaka M; Nakanishi M; Otsu M
Stem Cell Res Ther; 2019 Jun; 10(1):185. PubMed ID: 31234949
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
